68Ga-BC1

N/A

Report date: 2025/11/21 17:16:25

NME

Base Information

Drug Name68Ga-BC1

Drug Alias Name68Ga-BC1

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Gallium > 68Ga +[4]

Mechanisms of ActionPositron-emission tomography enhancersB-cell maturation protein modulators

TargetsB-cell maturation protein

Therapy Area/IndicationsMultiple MyelomaNeoplasms, Plasma Cell

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaPhase 1 Clinical

Originator CompaniesThe First Affiliated Hospital Of Beijing University

China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital Of Beijing University

Inactive CompaniesN/A

Active IndicationsMultiple MyelomaNeoplasms, Plasma Cell

Inactive IndicationsN/A

Other Information

ATC CodeN/A